AKNAD1 | AKNA domain containing 1 | | | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ARHGAP28 | Rho GTPase activating protein 28 | | | | | | Tissue enhanced |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | | | | | | Tissue enhanced |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | | | Tissue enhanced |
AUNIP | Aurora kinase A and ninein interacting protein | | | | | | Tissue enhanced |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | Enzymes
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
C11orf63 | Chromosome 11 open reading frame 63 | | | | | | Tissue enhanced |
C16orf46 | Chromosome 16 open reading frame 46 | | | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | | | | | | Tissue enhanced |
C18orf54 | Chromosome 18 open reading frame 54 | Predicted secreted proteins
| | | | | Tissue enhanced |
CALB2 | Calbindin 2 | Plasma proteins
| | | | | Tissue enhanced |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CBX2 | Chromobox homolog 2 | Disease related genes
| | | | | Tissue enhanced |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC15 | Coiled-coil domain containing 15 | | | | | | Tissue enhanced |
CCDC181 | Coiled-coil domain containing 181 | | | | | | Tissue enhanced |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CCNB3 | Cyclin B3 | | | | | | Tissue enhanced |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDCA2 | Cell division cycle associated 2 | | | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | | | | | | Tissue enhanced |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CENPU | Centromere protein U | | | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DFNB59 | Deafness, autosomal recessive 59 | Disease related genes
| | | | | Tissue enhanced |
DIAPH3 | Diaphanous-related formin 3 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DTL | Denticleless E3 ubiquitin protein ligase homolog (Drosophila) | | | | | | Tissue enhanced |
DZIP1 | DAZ interacting zinc finger protein 1 | | | | | | Tissue enhanced |
EFCAB13 | EF-hand calcium binding domain 13 | | | | | | Tissue enhanced |
EME1 | Essential meiotic structure-specific endonuclease 1 | | | | | | Tissue enhanced |
EPHA6 | EPH receptor A6 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM135B | Family with sequence similarity 135, member B | | | | | | Tissue enhanced |
FAM216A | Family with sequence similarity 216, member A | | | | | | Tissue enhanced |
FBF1 | Fas (TNFRSF6) binding factor 1 | | | | | | Tissue enhanced |
FIBCD1 | Fibrinogen C domain containing 1 | | | | | | Tissue enhanced |
GLT1D1 | Glycosyltransferase 1 domain containing 1 | | | | | | Tissue enhanced |
GSG2 | Germ cell associated 2 (haspin) | Enzymes
| | | | | Tissue enhanced |
HFM1 | HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae) | Enzymes
| | | | | Tissue enhanced |
HYLS1 | Hydrolethalus syndrome 1 | Disease related genes
| | | | | Tissue enhanced |
KIAA0895 | KIAA0895 | | | | | | Tissue enhanced |
KIF18A | Kinesin family member 18A | | | | | | Tissue enhanced |
KLHL35 | Kelch-like family member 35 | | | | | | Tissue enhanced |
LNP1 | Leukemia NUP98 fusion partner 1 | Disease related genes
| | | | | Tissue enhanced |
LRRC34 | Leucine rich repeat containing 34 | | | | | | Tissue enhanced |
MEX3B | Mex-3 RNA binding family member B | | | | | | Tissue enhanced |